Skip to main content

•    Replaces and repays the loan facility with Orbimed
•    Accelerates expansion of production and commercial capability, including the new territories reacquired from Sobi
•    Allows Pharming to extend its debt maturity profile through the period of development of its existing pipeline

Cookies: This website uses cookies Check the cookies page for more information Accept Decline